Formulation and Evaluation of Montelukast Sodium and Loratadine Orodispersible Tablet
Acta Poloniae Pharmaceutica - Drug Research · 17.06.2026 · 84 (1) · 73-88
DOI: 10.32383/appdr/222551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 17.06.2026. Verfasst von Asra Mansoor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Orodispersible tablets are intended to melt or dissolve in the mouth when taken orally. Montelukast sodium and Loratadine belong to BCS class II i.e. they have low solubility but high permeability characteristics. By merging natural or synthetic polymers, novel co-processed excipients like Ludiflash and Pharmaburst® are formed to enhance both stability and performance of dosage form. The aim of this study was to design and optimize orodispersible tablets (ODTs) of Montelukast sodium/Loratadine while evaluating their pre- and post-compression characteristics along with compatibility. Using direct compression technique, seven different formulations were manufactured by incorporating various excipients in different concentrations, including Ludiflash® and Pharmaburst®. All formulations underwent pre-formulation tests including bulk density, tapped density, angle of repose, etc. followed by post-compression tests like weight variation, thickness; diameter, hardness, wetting time, water dispersion, dissolution and disintegration. Formulation F6 was selected as optimized formulation as all parameters comply with USP standards. The optimized formulation (F6) showed high similarity in dissolution profiles (f1 = 0.27 < 15; f2 ≈ 100), indicating comparable in vitro dissolution performance. A simple, reliable, precise and accurate method of assay was developed by HPLC (Shimadzu, CTO-20AC). All the results found within the specified limits of the BP/USP. By the use of direct compression method, the development of ODTs of montelukast sodium/Loratadine having co-processed excipients, proved to be an effective approach with minimal excipients use. Moreover, the validated HPLC method established a simple, precise and reproducible technique for regular quality control assessments.
Zitieren
APA
Mansoor, A., Dilshad, H., Ali, H., Naveed, S., & Sadia, H. (2026). Formulation and Evaluation of Montelukast Sodium and Loratadine Orodispersible Tablet. Acta Poloniae Pharmaceutica - Drug Research, 84(1), 73-88. https://doi.org/10.32383/appdr/222551
Vancouver
Mansoor A, Dilshad H, Ali H, Naveed S, Sadia H. Formulation and Evaluation of Montelukast Sodium and Loratadine Orodispersible Tablet. Acta Poloniae Pharmaceutica - Drug Research. 2026;84(1):73-88. doi:10.32383/appdr/222551
BibTeX
@article{Mansoor2026,
author = {Mansoor, Asra and Dilshad, Huma and Ali, Huma and Naveed, Safila and Sadia, Halima},
title = {Formulation and Evaluation of Montelukast Sodium and Loratadine Orodispersible Tablet},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {84},
number = {1},
pages = {73--88},
doi = {10.32383/appdr/222551}
}
EUVIMED